Marshville Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6604 E Marshville Blvd, Marshville, NC 28103 Phone: 704-624-6300 Fax: 704-624-6302 |
Marshville Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7204 E Marshville Blvd, Marshville, NC 28103 Phone: 704-981-1664 |
Tran And Javed Dds Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 6604 E Marshville Blvd Ste 1, Marshville, NC 28103 Phone: 704-624-6300 |
J Greg Griffin Dds Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6604 E Marshville Blvd, Marshville, NC 28103 Phone: 704-624-9300 Fax: 704-624-0311 |
News Archive
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support the research of a new approach to treating metastatic cancer. Under this grant, valued at over $300,000, GenVec will investigate the hypothesis that the delivery of a specific gene will stimulate an antitumor response that could control cancer metastases.
In a Canadian first, Applied Brain Research Inc., and Ontario Centres of Excellence are pleased to announce that Intel's newest neuromorphic research chip, Loihi, will be demonstrated live at this year's Discovery conference.
An interview with Glyn Barnes, Marketing Director for AliveCor, about Kardia Mobile and the Kardia Band, the FDA approved devices which can provide a diagnostic quality ECG reading in 30 seconds.
Aphios Corporation today announced that it was awarded United States Patent No. 7,708,915 B2 for "Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein," granted May 04, 2010. This invention is an improved process to formulate polymeric microspheres and nanospheres, and encapsulate therapeutic proteins or other useful substances, and a polymer microspheres/nanospheres apparatus.
A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.
› Verified 1 days ago